| Nome |
# |
|
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy, file de3e52b3-186f-762d-e053-3705fe0a30e0
|
217
|
|
How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma, file de3e52b1-5a7c-762d-e053-3705fe0a30e0
|
129
|
|
Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology, file de3e52b3-0df2-762d-e053-3705fe0a30e0
|
78
|
|
Formaldehyde exposure and acute myeloid leukemia: A review of the literature, file de3e52b4-7474-762d-e053-3705fe0a30e0
|
36
|
|
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways, file de3e52b1-2d74-762d-e053-3705fe0a30e0
|
29
|
|
Altered Microrna Expression Profile in the peripheral Lymphomonocytes of Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw, file de3e52b3-1871-762d-e053-3705fe0a30e0
|
27
|
|
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity, file de3e52b0-d860-762d-e053-3705fe0a30e0
|
26
|
|
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies, file de3e52b0-0f14-762d-e053-3705fe0a30e0
|
25
|
|
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma, file de3e52b2-0a58-762d-e053-3705fe0a30e0
|
24
|
|
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients, file de3e52b0-ca30-762d-e053-3705fe0a30e0
|
23
|
|
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies, file de3e52b3-4f8f-762d-e053-3705fe0a30e0
|
22
|
|
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules, file de3e52b3-12f2-762d-e053-3705fe0a30e0
|
21
|
|
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma, file de3e52b0-4143-762d-e053-3705fe0a30e0
|
18
|
|
High BCR-ABL/GUS(IS) levels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib, file de3e52b1-35d6-762d-e053-3705fe0a30e0
|
18
|
|
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy, file de3e52b3-5f6b-762d-e053-3705fe0a30e0
|
18
|
|
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma, file de3e52b0-358a-762d-e053-3705fe0a30e0
|
17
|
|
Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient., file de3e52b0-ece2-762d-e053-3705fe0a30e0
|
17
|
|
Differences among young adults, adults and elderly chronic myeloid leukemia patients, file de3e52b0-3689-762d-e053-3705fe0a30e0
|
16
|
|
LncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome, file de3e52b2-024e-762d-e053-3705fe0a30e0
|
13
|
|
Role of the microbiota in hematologic malignancies., file de3e52b2-0a5b-762d-e053-3705fe0a30e0
|
12
|
|
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms, file de3e52b1-6047-762d-e053-3705fe0a30e0
|
11
|
|
Antitumorigenic action of nelfinavir: Effects on multiple myeloma and hematologic malignancies (Review), file b216e468-886c-42ad-9736-a8d64f37349f
|
10
|
|
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients, file de3e52b0-4144-762d-e053-3705fe0a30e0
|
10
|
|
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways, file de3e52b2-b443-762d-e053-3705fe0a30e0
|
9
|
|
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study, file de3e52b3-26a6-762d-e053-3705fe0a30e0
|
9
|
|
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors, file de3e52ae-c28a-762d-e053-3705fe0a30e0
|
7
|
|
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells, file de3e52b0-c88e-762d-e053-3705fe0a30e0
|
7
|
|
Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw., file de3e52b2-0a11-762d-e053-3705fe0a30e0
|
7
|
|
Immune thrombocytopenia: options and new perspectives, file de3e52b5-6a9e-762d-e053-3705fe0a30e0
|
7
|
|
Radioprotective agents and enhancers factors. Preventive and therapeutic strategies for oxidative induced radiotherapy damages in hematological malignancies, file de3e52b5-7b70-762d-e053-3705fe0a30e0
|
7
|
|
Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study., file de3e52ae-a0f9-762d-e053-3705fe0a30e0
|
6
|
|
A micro-Raman spectroscopic investigation of leukemic U-937 cells in aged cultures, file de3e52af-fa39-762d-e053-3705fe0a30e0
|
6
|
|
Vaccination strategies in lymphoproliferative disorders: Failures and successes, file de3e52b0-413f-762d-e053-3705fe0a30e0
|
6
|
|
Standardisation of minimal residual disease in multiple myeloma, file de3e52b1-5f45-762d-e053-3705fe0a30e0
|
6
|
|
Nanobodies and Cancer: Current Status and New Perspectives, file de3e52b1-be00-762d-e053-3705fe0a30e0
|
6
|
|
Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines, file de3e52b2-b5ed-762d-e053-3705fe0a30e0
|
6
|
|
null, file de3e52ae-eb8d-762d-e053-3705fe0a30e0
|
5
|
|
Titanium miniplates: a new risk factor for the development of the bisphosphonate-related osteonecrosis of the jaw, file de3e52ae-f2ec-762d-e053-3705fe0a30e0
|
5
|
|
Phage-AgNPs complex as SERS probe for U937 cell identification, file de3e52af-3315-762d-e053-3705fe0a30e0
|
5
|
|
The metabolomic signature of hematologic malignancies, file de3e52b0-3938-762d-e053-3705fe0a30e0
|
5
|
|
Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates, file de3e52b0-add5-762d-e053-3705fe0a30e0
|
5
|
|
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies, file de3e52b0-c76d-762d-e053-3705fe0a30e0
|
5
|
|
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma., file de3e52b1-3274-762d-e053-3705fe0a30e0
|
5
|
|
Sarcoglycans and integrins in gingival epithelium during biphosphonates treatment: immunohistochemical study, file de3e52b2-0243-762d-e053-3705fe0a30e0
|
5
|
|
Preliminary Results of a Prospective Observational Study to Assess the Prevalence of Gaucher Disease in an Adult Population Affected By MGUS., file de3e52b3-0856-762d-e053-3705fe0a30e0
|
5
|
|
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma, file de3e52b3-2acf-762d-e053-3705fe0a30e0
|
5
|
|
Efficacia della chemioterapia convenzionale ad alte dosi in un caso di mieloma multiplo IgM primitivamente doppio-refrattario ai nuovi farmaci, file de3e52b3-4381-762d-e053-3705fe0a30e0
|
5
|
|
Results of high dose of imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase trial of the GIMEMA Working Party, file de3e52ae-b004-762d-e053-3705fe0a30e0
|
4
|
|
Lymphoproliferative disease and cancer among patients with common variable immunodeficiency, file de3e52b0-357f-762d-e053-3705fe0a30e0
|
4
|
|
Vaccination of multiple myeloma: Current strategies and future prospects, file de3e52b0-397d-762d-e053-3705fe0a30e0
|
4
|
|
A rare spinal localization of gray zone lymphoma without mediastinal involvement: A case report and review of literature, file de3e52b3-38a6-762d-e053-3705fe0a30e0
|
4
|
|
Extramedullary plasmacytoma of the maxilla simulating a maxillary radicular cyst: Quick diagnosis and management, file de3e52b4-12a4-762d-e053-3705fe0a30e0
|
4
|
|
The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients, file de3e52b4-b5a4-762d-e053-3705fe0a30e0
|
4
|
|
New frontiers about the role of human microbiota in immunotherapy: The immune checkpoint inhibitors and CAR T-cell therapy era, file de3e52b5-6f89-762d-e053-3705fe0a30e0
|
4
|
|
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies, file de3e52b5-79ef-762d-e053-3705fe0a30e0
|
4
|
|
Anxiety, Depression, Distress, and Resilience in Patients with Haematological Malignancies. The Effect of Nine Weeks of Psychological Support on Psychological Status and Stress Biological Markers, file 15cd8ea2-2b81-4e3e-8005-1b31c9334534
|
3
|
|
Phage-phenotype imaging of myeloma plasma cells by phage display, file 228758a2-e831-4354-ad23-1db5947d4888
|
3
|
|
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws, file de3e52ae-c415-762d-e053-3705fe0a30e0
|
3
|
|
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer., file de3e52ae-db44-762d-e053-3705fe0a30e0
|
3
|
|
Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera., file de3e52ae-dbd5-762d-e053-3705fe0a30e0
|
3
|
|
Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: Results of the multicenter O-CLL1-GISL study, file de3e52b0-3bd6-762d-e053-3705fe0a30e0
|
3
|
|
Challenge test to
bisphosphonates in patients with hypersensitivity reactions to drugs., file de3e52b0-5aa7-762d-e053-3705fe0a30e0
|
3
|
|
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells, file de3e52b0-a5eb-762d-e053-3705fe0a30e0
|
3
|
|
The cancer stem cell hypothesis: a guide to potential molecular targets., file de3e52b0-f596-762d-e053-3705fe0a30e0
|
3
|
|
Spontaneous Healing of Clodronate-Related Osteonecrosis of the Jaw, file de3e52b1-0d1c-762d-e053-3705fe0a30e0
|
3
|
|
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura, file de3e52b4-7119-762d-e053-3705fe0a30e0
|
3
|
|
Immunohistochemical evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw., file de3e52ae-c08c-762d-e053-3705fe0a30e0
|
2
|
|
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1., file de3e52ae-db49-762d-e053-3705fe0a30e0
|
2
|
|
The usage of Raman spectroscopy in the identification of cellular systems, file de3e52ae-f11d-762d-e053-3705fe0a30e0
|
2
|
|
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features., file de3e52ae-f2ee-762d-e053-3705fe0a30e0
|
2
|
|
Osteonecrosis, file de3e52ae-f8da-762d-e053-3705fe0a30e0
|
2
|
|
Castleman–Kojima disease (TAFRO syndrome) in a Caucasian patient: A rare case report and review of the literature, file de3e52af-33f7-762d-e053-3705fe0a30e0
|
2
|
|
Telomerase and telomere biology in hematological diseases: A new therapeutic target, file de3e52b0-c35e-762d-e053-3705fe0a30e0
|
2
|
|
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies, file de3e52b4-5338-762d-e053-3705fe0a30e0
|
2
|
|
The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention, file de3e52b4-60de-762d-e053-3705fe0a30e0
|
2
|
|
SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma, file de3e52b5-11f6-762d-e053-3705fe0a30e0
|
2
|
|
A multivariate analysis of Multiple Myeloma subtype plasma cells, file de3e52b5-2462-762d-e053-3705fe0a30e0
|
2
|
|
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma, file 3c6f2dcd-fb51-4aa2-bab6-1f5e70a38ec9
|
1
|
|
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study, file 4241e7db-8037-4992-adec-ffdd82abd2ef
|
1
|
|
Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology, file 9863ae22-35da-4928-88c8-c66002632bcc
|
1
|
|
Evaluation of Interleukin-17 serum levels in patients with chronic myeloproliferative diseases., file de3e52ae-a2af-762d-e053-3705fe0a30e0
|
1
|
|
Reduced serum levels of interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration, file de3e52ae-be4a-762d-e053-3705fe0a30e0
|
1
|
|
Osteosclerotic myeloma with spinal leptomeningitis and severe polyneuropathy: A case report, file de3e52ae-c4f1-762d-e053-3705fe0a30e0
|
1
|
|
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation, file de3e52ae-c4fe-762d-e053-3705fe0a30e0
|
1
|
|
Efficacia di Nilotinib in un giovane paziente affetto da LMC ad alto rischio Sokal in fallimento dopo inatinib ad alte dosi, file de3e52ae-d44e-762d-e053-3705fe0a30e0
|
1
|
|
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients., file de3e52ae-d73c-762d-e053-3705fe0a30e0
|
1
|
|
Fludarabine based treatment caused improvement of anemia in a patient with T-cell LGL leukemia despite evidence of the persistence of the abnormal T-cell clone., file de3e52ae-db4b-762d-e053-3705fe0a30e0
|
1
|
|
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab., file de3e52ae-ef7d-762d-e053-3705fe0a30e0
|
1
|
|
Oxidative stress in oncohematologic diseases: an update., file de3e52ae-f9dc-762d-e053-3705fe0a30e0
|
1
|
|
Low-energy laser irradiation promotes cellular damage in glucocorticoid-resistant multiple myeloma cells., file de3e52af-2bb5-762d-e053-3705fe0a30e0
|
1
|
|
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia, file de3e52b0-3407-762d-e053-3705fe0a30e0
|
1
|
|
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment, file de3e52b0-3a2e-762d-e053-3705fe0a30e0
|
1
|
|
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome, file de3e52b0-3cbc-762d-e053-3705fe0a30e0
|
1
|
|
Increased serum levels of interleukin-31 could modulate inflammatory processes in multiple sclerosis, file de3e52b0-5601-762d-e053-3705fe0a30e0
|
1
|
|
Genetic risk of prediabetes and diabetes development in chronic myeloid leukemia patients treated with nilotinib, file de3e52b1-3c62-762d-e053-3705fe0a30e0
|
1
|
|
null, file de3e52b1-6174-762d-e053-3705fe0a30e0
|
1
|
|
Curcumin Ameliorates the In Vitro Efficacy of Carfilzomib in Human Multiple Myeloma U266 Cells Targeting p53 and NF-κB Pathways., file de3e52b1-b8c2-762d-e053-3705fe0a30e0
|
1
|
|
Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients, file de3e52b1-fc8e-762d-e053-3705fe0a30e0
|
1
|
|
Relationship between mitofusin 2 and cancer., file de3e52b2-0a0f-762d-e053-3705fe0a30e0
|
1
|
|
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib, file de3e52b2-34e1-762d-e053-3705fe0a30e0
|
1
|
| Totale |
1.071 |